ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 221

Detection Of Cerebral Microvascular Lesions In Patients With Acute Phase Neuropsychiatric Systemic Lupus Erythematosus By 7Tesla MRI

Nobuhito Sasaki1, Okinori Murata1, Yukari Ninomiya1, Yuka Oikawa1, Hitoshi Kobayashi1, Kohei Yamauchi1, Makoto Sasaki2, Takashi Sawai3 and Yutaka Nakamura1, 1Division of Pulmonary medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan, 2Division of Ultrahigh Field MRI, Iwate Medical University School of Medicine, Morioka, Japan, 3Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Diagnostic imaging, MRI, neuropsychiatric disorders and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases I: Imaging in Gout, Pediatric, Soft and Connective Tissue Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: The cerebral microvascular lesions of patients with neuropsychiatric systemic lupus erythematosus (NPSLE) have not been fully elucidated. The 7Tesla MR scanner has high image resolution and can be expected to detect cerebral microvascular lesions that have never before been visible. We examined the cerebral microvascular lesions of NPSLE using a 7Tesla MR scanner.

Methods: We studied 7 acute phase-NPSLE patient and 11 non-NPSLE. MRI was performed using a 1.5Tesla MR scanner and 7Tesla MR scanner (T1-weighted imaging, T2-weighted imaging, diffusion-weighted imaging, magnetic resonance angiography). Two radiologists performed the interpretation without clinical information. Diagnosis of was determined by a neurologist, psychiatrist and rheumatologist.

Results: Examination by the 7Tesla MRI revealed cerebral microvascular lesions(under 100 micrometer) in 6 of 7 NPSLE patient. These findings were not detected in any of the patients with non-NP SLE. These findings were not detected by 1.5 Tesla MRI. There were not findings at all in 1.5TeslaMRI, and the case that included findings was found in only 7TeslaMRI. The cerebral microvascular lesions were found around the central sulcus especially in T2-weighted image. These MRI findings disappeared after central nervous symptom improvement in two of the three NPSLE patient that reexamined three months later. However, we did not find a direct association between the MRI findings and the neuropsychology dysfunction.

ACR-image.jpg

Image:41 years old female She had both legs motor nerve disorder.

The cerebral microvascular lesions were found around the central sulcus in T2-weighted image. It could be find only by using 7TeslaMRI.

Conclusion: Cerebral microvascular lesions could be detected in patients with NPSLE by 7 Tesla MRI, suggesting that 7 Tesla MRI is a useful tool for diagnosing the cerebral lesions of NPSLE. It will be necessary to elucidate the association between cerebral microvascular lesions and neuropsychological dysfunction.


Disclosure:

N. Sasaki,

JSPS KAKENHI ,

2;

O. Murata,
None;

Y. Ninomiya,
None;

Y. Oikawa,
None;

H. Kobayashi,
None;

K. Yamauchi,
None;

M. Sasaki,
None;

T. Sawai,
None;

Y. Nakamura,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detection-of-cerebral-microvascular-lesions-in-patients-with-acute-phase-neuropsychiatric-systemic-lupus-erythematosus-by-7tesla-mri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology